en

PRODUCT DETAIL

Apremilast STADA 30 mg filmom obalené tablety

Code 9034E
MA number 59/0058/25-S
Product Form: tbl flm 56x1x30 mg (blis.PVC/Al - jednotk.bal.)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
MAH, country: STADA Arzneimittel AG, Germany
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AA Selective immunosuppressants
L04AA32 Apremilast
Shelf life: 60
Container: blister PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 24.02.2025
Validity: 24.02.2030
PIL: PIL_Apremilast STADA_02.2025.pdf  
SPC: SPC_Apremilast STADA_02.2025.pdf  
Safety feature Yes
Data update: 26.02.2025
eu-flag.png sk-flag.png